|
|
|
|
||
Re: Sarepta updates its rollover study of the 12 boys in their phase II trial with last followup anticipated Feb., 201710 of 12. Two were started turned non-ablitory before the 24 weeks of medication were up. The key looks like treatment needs to start at age 7. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
12266 | Re: Sarepta updates its rollover study of the 12 boys in their phase II trial with last followup anticipated Feb., 2017 | pineappleguava | 1 | 12/2/2016 10:44:08 AM |